Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Payables: 2012-2024

Historic Payables for CorMedix (CRMD) over the last 10 years, with Dec 2024 value amounting to $1.7 million.

  • CorMedix's Payables rose 1422.09% to $20.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.9 million, marking a year-over-year increase of 202.22%. This contributed to the annual value of $1.7 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, CorMedix's Payables is $1.7 million, which was down 21.89% from $2.2 million recorded in FY2022.
  • In the past 5 years, CorMedix's Payables registered a high of $2.2 million during FY2021, and its lowest value of $1.1 million during FY2020.
  • Moreover, its 2-year median value for Payables was $2.0 million (2022), whereas its average is $2.0 million.
  • As far as peak fluctuations go, CorMedix's Payables skyrocketed by 95.86% in 2021, and later dropped by 0.34% in 2022.
  • Yearly analysis of 4 years shows CorMedix's Payables stood at $1.1 million in 2020, then soared by 95.86% to $2.2 million in 2021, then declined by 0.34% to $2.2 million in 2022, then reached $1.7 million in 2024.